HIV Pathogenesis Resource Center Features

• Viral Rebound Rates Decrease Over Time in Suppressed Patients Viral rebound risk exists for people who've fully suppressed HIV replication. What does UK cohort study data show for rebound rates for suppressed patients with and without treatment failure history?
  AIDS Clinical Care, July 01, 2007
• The New York Course 2007: HIV Pathogenesis -- Expert Interview HIV Management 2007: Dr. Douek speaks with Medscape about the crucial role of profound, early, and persistent depletion of CD4 cells in the gut and the gut's subsequent role in T-cell activation.
  Medscape HIV/AIDS, May 14, 2007
• Improving Laboratory Testing in Resource-Limited Settings John S.J. Brooks, MD, FASC, President of the ASCP, describes the laboratory efforts in African AIDS.
  March 30, 2007
• 14th Conference on Retroviruses and Opportunistic Infections Read clinically focused news coverage of key developments from the meeting.
  March 29, 2007
• Bartlett HIV/AIDS Review: November 30, 2004 John Bartlett reviews new data on ARV trials: when to start, PI tolerability, drug resistance in blips & advanced disease, MAC tx, hepatotox of rifampin/pyrazinamide for TB, anemia in HIV, & more.
  Medscape HIV/AIDS, March 15, 2007
• Bartlett Expert Reviews and Commentary: HIV/AIDS, Sept 30, 2006 Dr. Bartlett reviews baseline/tx factors and immunologic recovery on HAART; pharmacogenetics: EFV/NFV; detection of acute HIV infections; prevalence of transmitted HIV drug resistance; and more.
  Medscape HIV/AIDS, September 19, 2006
• AIDS 2006: XVI International AIDS Conference AIDS 2006: Read the latest advances in treating HIV/AIDS, from the International AIDS Conference in Toronto.
  September 19, 2006
• Mixed Cryptosporidium Infections and HIV Mixed infections may occur more frequently than previously believed and should be considered when assessing cryptosporidiosis.
  Emerging Infectious Diseases, June 01, 2006
• 13th Conference on Retroviruses and Opportunistic Infections CROI 2006: Learn the latest advances in HIV/AIDS in these summaries.
  March 17, 2006
• Highlights of 14th Annual Canadian Conf on HIV/AIDS Research Dr. Brian Conway, the conference's chairperson, reviews the most signficant data on treatment of IDUs, DOT, treatment simplication and interruptions, tenofovir safety/tolerability, and more.
  Medscape HIV/AIDS, September 13, 2005
• 3rd IAS Conference on HIV Pathogenesis and Treatment From IAS-Rio 2005: Learn the latest about management of HIV and related conditions, and new data on pathogenesis, prevention strategies, global epidemiology, and care in resource-poor settings.
  August 31, 2005
• Highlights of the 16th ISSTDR Meeting Dr. Myron Cohen reviews the most critical clinical, epidemiologic, and basic scientific data from this key biennial meeting on sexually transmitted diseases.
  Medscape Infectious Diseases, August 18, 2005
• HIV/AIDS: July 15, 2005 Dr. John G. Bartlett reviews groundbreaking new data on HIV and immune function; HIV transmission by coital act and disease stage; ART and pharmacogenomics; diabetes and ART in MACS, and more.
  Medscape HIV/AIDS, July 14, 2005
• Bartlett HIV/AIDS Review: May 15, 2005 Dr. John Bartlett reviews drug resistance after STIs and viral blips, ART simplication strategies, mother-to-child HIV transmission, nevirapine hepatotoxicity, OIs & HAART, HIV/HCV treatment, & more.
  Medscape HIV/AIDS, May 17, 2005
• 12th Conference on Retroviruses and Opportunistic Infections Read clinically focused news coverage of key developments from the meeting.
  March 28, 2005
• Hepatitis B Virus Markers in Romanian Adolescents With HIV This article evaluates the frequency of hepatitis coinfection in Romanian adolescents who were diagnosed with HIV prior to 1995.
  March 28, 2005
• Substitutions in RT and PR Genes of HIV-1 Subtype B An analysis of the rate of different nucleotide substitutions in clinical samples in the RT and PR regions of patients harboring subtype-B HIV-1 viruses.
  March 24, 2005
• Pregnancy and Other Factors Associated With Higher CD4+ T Cells The impact of routine screening of pregnant women and other factors on the stage of HIV disease at diagnosis were evaluated.
  March 15, 2005
• Bartlett HIV/AIDS Review: January 15, 2005 Dr. Bartlett reviews recent data on when to start ART, ABC or AZT + 3TC/EFV, resistance in treated pts w/low-level viremia, rapid HIV testing, pneumocystis pneumonia, HHV-8 infection and KS, and more.
  Medscape HIV/AIDS, January 27, 2005
• Bartlett HIV/AIDS Review: December 15, 2004 Dr. Bartlett reviews the new DHHS treatment guidelines & data on HAART, anemia & HIV, coinfection w/HIV & HBV or HCV, new HIV prevention strategies, TB treatment in HAART-treated patients, and more.
  Medscape HIV/AIDS, December 28, 2004